Tau PET brain imaging could launch precision medicine era for Alzheimer’s disease UNIVERSITY OF CALIFORNIA – SAN FRANCISCO Brain imaging of pathological tau-protein “tangles” reliably predicts the location of future brain atrophy in Alzheimer’s patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and...
Category: <span>Alzheimer’s</span>
Post
Study: Minimum dose of hydromethylthionine could slow cognitive decline in mild-to-moderate Alzheimer’s
by IOS Press Credit: CC0 Public Domain In a paper published in today’s online issue of the Journal of Alzheimer’s Disease, TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer’s disease. These...
Post
Exploring how lipids and cholesterol relate to Alzheimer’s
by Lorena Anderson, University of California Credit: iStock/iLexx Professor Jing Xu and her students study extremely tiny motor proteins, but their work could make a huge contribution to the growing body of knowledge about Alzheimer’s and other diseases that progressively destroy brain tissue. Alzheimer’s disease is, so far, untreatable and incurable and is the sixth...
Post
NASA, industry partner for space-based study of potential Alzheimer’s key
by Jennifer Harbaugh, NASA An innovative experiment underway on the International Space Station could help researchers make new progress in the fight against aggressive neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The Ring-Sheared Drop experiment, developed and led by Teledyne Brown Engineering of Huntsville, Alabama, will be housed in the station’s Microgravity Science Glovebox to...
Post
Escaping Alzheimer’s
There is, in Colombia, a family with a tragic legacy of forgetfulness. “People in this large family get Alzheimer’s like clockwork at age 45-50,” said UC Santa Barbara neuroscientist Kenneth S. Kosik, the campus’s Harriman Professor of Neuroscience and co-director of the Neuroscience Research Institute. Their aggressive, genetic form of the disease has been passed...
Post
Study finds key Alzheimer’s gene (APOE) acts differently in Caribbean Hispanics
Researcher says understanding genetic risk of a disease requires diverse gene pool UNIVERSITY OF WASHINGTON HEALTH SCIENCES/UW MEDICINE Researchers looking to unlock the mysteries of Alzheimer’s disease have revealed new insights from old variants. A gene called apolipoprotein E (APOE), long implicated in Alzheimer’s disease, has two variants that act differently among Caribbean Hispanics depending...
Post
Cognitive screen paired with odor identification predicts lack of transition to dementia
Alzheimer’s may be ruled out with brief smell and cognitive tests COLUMBIA UNIVERSITY IRVING MEDICAL CENTER Summary A new study has found that performing well on two brief tests measuring cognitive ability and ability to identify odors indicates very low risk for Alzheimer’s. We know that these tests can help predict the risk of developing dementia, but didn’t...
Post
Phoenix-based company believes it has discovered major breakthrough in Alzheimer’s treatment
By Linda Williams | Published 8 hours ago | Special Reports | FOX 10 Phoenix PHOENIX – Alzheimer’s disease robs millions of people of their memory and their lives, and even after years of research, there’s still no cure. A Phoenix-based company thinks it may have discovered a treatment that stops, even reverses the process....
Post
In shocking reversal, Biogen to submit experimental Alzheimer’s drug for approval
By MATTHEW HERPER @matthewherper OCTOBER 22, 2019 In a shocking reversal, Biogen (BIIB) on Tuesday said that it would resurrect an Alzheimer’s drug that the company previously said had failed and will ask the Food and Drug Administration to approve it. The company said a “new analysis of larger dataset” showed that the drug, aducanumab,...
Post
Otago scientists’ discovery leads to greater understanding of Alzheimer’s disease
UNIVERSITY OF OTAGO Otago scientists have made an important discovery in understanding the role a particular protein plays to impair memory in Alzheimer’s disease, which could lead to more effective treatment in future. Professor Cliff Abraham and Dr Anurag Singh from the Department of Psychology have identified that a protein in the brain – tumor...